Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults

for the International Headache Society Clinical Trials Standing Committee

doi:10.1177/0333102418758283

Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults

for the International Headache Society Clinical Trials Standing Committee

Research output: Contribution to journal › Article › peer-review

325 Scopus citations

Abstract

Background: Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. In 2008, the Committee published the first specific guidelines on chronic migraine. Subsequent advances in drug, device, and biologicals development, as well as novel trial designs, have created a need for a revision of the chronic migraine guidelines. Objective: The present update is intended to optimize the design of controlled trials of preventive treatment of chronic migraine in adults, and its recommendations do not apply to trials in children or adolescents.

Original language	English
Pages (from-to)	815-832
Number of pages	18
Journal	Cephalalgia
Volume	38
Issue number	5
DOIs	https://doi.org/10.1177/0333102418758283
State	Published - 1 Apr 2018

Keywords

Chronic migraine
clinical trials
drugs
headache
preventive treatment

Access to Document

10.1177/0333102418758283

Cite this

@article{6e19b76f4e374d87ac562cad88659132,

title = "Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults",

abstract = "Background: Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. In 2008, the Committee published the first specific guidelines on chronic migraine. Subsequent advances in drug, device, and biologicals development, as well as novel trial designs, have created a need for a revision of the chronic migraine guidelines. Objective: The present update is intended to optimize the design of controlled trials of preventive treatment of chronic migraine in adults, and its recommendations do not apply to trials in children or adolescents.",

keywords = "Chronic migraine, clinical trials, drugs, headache, preventive treatment",

author = "\{for the International Headache Society Clinical Trials Standing Committee\} and Cristina Tassorelli and Diener, \{Hans Christoph\} and Dodick, \{David W.\} and Silberstein, \{Stephen D.\} and Lipton, \{Richard B.\} and Messoud Ashina and Becker, \{Werner J.\} and Ferrari, \{Michel D.\} and Goadsby, \{Peter J.\} and Patricia Pozo-Rosich and Wang, \{Shuu Jiun\}",

note = "Publisher Copyright: {\textcopyright} 2018, {\textcopyright} International Headache Society 2018.",

year = "2018",

month = apr,

day = "1",

doi = "10.1177/0333102418758283",

language = "English",

volume = "38",

pages = "815--832",

journal = "Cephalalgia",

issn = "0333-1024",

publisher = "SAGE Publications Ltd",

number = "5",

}

TY - JOUR

T1 - Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults

AU - for the International Headache Society Clinical Trials Standing Committee

AU - Tassorelli, Cristina

AU - Diener, Hans Christoph

AU - Dodick, David W.

AU - Silberstein, Stephen D.

AU - Lipton, Richard B.

AU - Ashina, Messoud

AU - Becker, Werner J.

AU - Ferrari, Michel D.

AU - Goadsby, Peter J.

AU - Pozo-Rosich, Patricia

AU - Wang, Shuu Jiun

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Background: Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. In 2008, the Committee published the first specific guidelines on chronic migraine. Subsequent advances in drug, device, and biologicals development, as well as novel trial designs, have created a need for a revision of the chronic migraine guidelines. Objective: The present update is intended to optimize the design of controlled trials of preventive treatment of chronic migraine in adults, and its recommendations do not apply to trials in children or adolescents.

AB - Background: Quality clinical trials form an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. In 2008, the Committee published the first specific guidelines on chronic migraine. Subsequent advances in drug, device, and biologicals development, as well as novel trial designs, have created a need for a revision of the chronic migraine guidelines. Objective: The present update is intended to optimize the design of controlled trials of preventive treatment of chronic migraine in adults, and its recommendations do not apply to trials in children or adolescents.

KW - Chronic migraine

KW - clinical trials

KW - drugs

KW - headache

KW - preventive treatment

UR - https://www.scopus.com/pages/publications/85043682418

U2 - 10.1177/0333102418758283

DO - 10.1177/0333102418758283

M3 - Article

C2 - 29504482

AN - SCOPUS:85043682418

SN - 0333-1024

VL - 38

SP - 815

EP - 832

JO - Cephalalgia

JF - Cephalalgia

IS - 5

ER -

Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this